Norway
# |
Name |
EBT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
20.82%
|
Dec. 31, 2023 | USD 1.26 | -2.20% |
|
Norway |
|
2 |
14.17%
|
Dec. 31, 2024 | USD 17.56 | 0.15% |
|
Norway |
|
3 |
2.12%
|
Dec. 31, 2023 | USD 2.21 | -0.65% |
|
Norway |
|
4 |
1.95%
|
Dec. 31, 2023 | USD 5.25 | 2.05% |
|
Norway |
|
5 |
-7.61%
|
Dec. 31, 2023 | USD 4.31 | 4.92% |
|
Norway |
|
6 |
-54.75%
|
Dec. 31, 2023 | USD 0.27 | 1.85% |
|
Norway |
|
7 |
-269.92%
|
Dec. 31, 2023 | USD 1.13 | -2.55% |
|
Norway |
|
8 |
-341.70%
|
Dec. 31, 2023 | USD 0.23 | -0.24% |
|
Norway |
|
9 |
-679.43%
|
Dec. 31, 2023 | USD 0.11 | -0.62% |
|
Norway |
|
10 |
-53,785.59%
|
Dec. 31, 2023 | USD 0.73 | 3.02% |
|
Norway |
The Biotechnology company in Norway with the highest EBT Margin is ArcticZymes Technologies ASA (Oslo Stock Exchange: AZT.OL) at 20.82%.
The Biotechnology company in Norway with the lowest EBT Margin is BerGenBio ASA (Oslo Stock Exchange: BGBIO.OL) at -53,785.59%.
The top 10 Biotechnology companies in Norway by EBT Margin are ArcticZymes Technologies ASA, Borregaard ASA, Navamedic ASA, Photocure ASA, Gentian Diagnostics ASA, Hofseth BioCare ASA, Lifecare AS, Nykode Therapeutics AS, PCI Biotech Holding ASA and BerGenBio ASA.
The bottom 10 Biotechnology companies in Norway by EBT Margin are BerGenBio ASA, PCI Biotech Holding ASA, Nykode Therapeutics AS, Lifecare AS, Hofseth BioCare ASA, Gentian Diagnostics ASA, Photocure ASA, Navamedic ASA, Borregaard ASA and ArcticZymes Technologies ASA.